68 /100
HIGH RISK
Score updated Jul 14, 2026

ENSC — Ensysce Biosciences, Inc. Dilution Risk Tracker

Track ENSC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENSC — Get alerts when the score changes →

As of July 14, 2026, Ensysce Biosciences, Inc. (ENSC) has a DilutionWatch DilutionScore of 68/100, rated HIGH dilution risk. Ensysce Biosciences, Inc. has a market capitalization of $4.13M, 14.69M shares outstanding, 15 institutional holders tracked. Key dilution vectors include 880.0K outstanding warrants, approximately 1 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
20
⚠️ Warrant Exposure
30
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
59%
🔄 Reverse Split 70%
• 50-day avg $0.43 below $1 exchange minimum
• Only 1 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 0.7 months cash remaining
🔁 Convertible Conversion 40%
• Significant convertible debt: 23% potential dilution
• Elevated convertible risk (60/100)
🔔 Track ENSC — Get forecast alerts →

💹 Market Data

Market Cap$4.13M
Shares Outstanding14.69M
Float14.68M
Cash$745.5K
Debt$245.8K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 16.0% shares (2026Q1 vs prior)
15 institutional holders · 586.5K shares
#1 PERCEPTIVE ADVISORS LLC 173.3K shares
#2 ADAGE CAPITAL PARTNERS GP, L.L.C. 149.7K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 73.9K shares
+ 12 more holders Sign up free to view →

📉 Short Interest

Short Interest182.4K
Days to Cover1.0
% of Float1.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for ENSC Shareholders

Ensysce Biosciences, Inc. (ENSC) has a DilutionScore of 68/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 880,000 outstanding warrants for ENSC. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: ENSC has approximately 1 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for ENSC in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ENSC alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track ENSC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ENSC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ENSC
📊 ENSC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ENSC Signal Convergence & Dark Pool Activity — StonkWhisper 📄 ENSC Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.